Additionally, we performed immunohistochemistry assays to confirm whether FoxP3 is associated with the clinicopathological features of RCC and designed a nude mice orthotopic RCC model to verify FoxP3 function in vivo. This evidence concerns the gene FOXP3 and renal cell carcinoma.